GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

GH · Jun 30, 2026

Guardant Health, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]

Inspectable configuration

State dimensions

Filing0001576280-26-000037General Corporate

Debt relative to revenueRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.debt_to_revenue

448.67% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensity30thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

3.51% · OPTIONAL · VALID

Operating cash generation95thOwn-history percentile · N=20

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-17.25% · OPTIONAL · VALID

Revenue growth95thOwn-history percentile · N=20

Evidence method

Yoy · gp.fundamentals.revenue

44.33% · CORE · VALID

Inventory pressure40thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

31.48% · OPTIONAL · VALID

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

65.39% · CORE · NOT_ENOUGH_HISTORY

Operating margin95thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.operating_margin

-38.55% · CORE · VALID

R&D intensity0thOwn-history percentile · N=20

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

28.82% · OPTIONAL · VALID

SBC intensity40thOwn-history percentile · N=20

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

17.23% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History22 statesSelf-history eligible

Period transition

What moved in the state?

Balance Sheet Leverage Decreased

Previous: 498.39%
Current: 448.67%
Delta: -49.72%

Capex Intensity Increased

Previous: 1.85%
Current: 3.51%
Delta: 1.66%

Cash Generation Increased

Previous: -21.75%
Current: -17.25%
Delta: 4.51%

Growth Decreased

Previous: 48.26%
Current: 44.33%
Delta: -3.93%

Inventory Pressure Increased

Previous: 27.80%
Current: 31.48%
Delta: 3.69%

Margin Increased

Previous: 65.22%
Current: 65.39%
Delta: 0.17%

Profitability Increased

Previous: -40.23%
Current: -38.55%
Delta: 1.68%

R And D Intensity Decreased

Previous: 30.18%
Current: 28.82%
Delta: -1.36%

Sbc Intensity Increased

Previous: 15.78%
Current: 17.23%
Delta: 1.45%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Sep 30, 2025

Similarity: 92%
Compared: 7 dimensions
Coverage: 100%

Growth 0.6 · Profitability 5.0 · Sbc Intensity 20.0 · Capex Intensity 0.0 · Cash Generation 0.0 · R And D Intensity 0.0 · Inventory Pressure 5.0

Mar 31, 2026

Similarity: 84%
Compared: 7 dimensions
Coverage: 100%

Growth 5.0 · Profitability 0.0 · Sbc Intensity 30.0 · Capex Intensity 25.0 · Cash Generation 15.0 · R And D Intensity 0.0 · Inventory Pressure 10.0

Dec 31, 2024

Similarity: 83%
Compared: 7 dimensions
Coverage: 100%

Growth 15.0 · Profitability 10.8 · Sbc Intensity 2.1 · Capex Intensity 3.7 · Cash Generation 26.6 · R And D Intensity 10.5 · Inventory Pressure 29.5

Mar 31, 2024

Similarity: 83%
Compared: 7 dimensions
Coverage: 100%

Growth 11.7 · Profitability 1.3 · Sbc Intensity 27.5 · Capex Intensity 17.5 · Cash Generation 1.3 · R And D Intensity 6.3 · Inventory Pressure 28.8

Mar 31, 2023

Similarity: 62%
Compared: 7 dimensions
Coverage: 100%

Growth 7.5 · Profitability 28.3 · Sbc Intensity 31.7 · Capex Intensity 30.0 · Cash Generation 61.7 · R And D Intensity 58.3 · Inventory Pressure 10.0

Research Graph

Related governed research

Compared To · Services-Medical Laboratories peers →Analogous To · GH state analogue 5 →Analogous To · GH state analogue 2 →Analogous To · GH state analogue 3 →Analogous To · GH state analogue 4 →Analogous To · GH state analogue 1 →Has State · Guardant Health, Inc. →Transitioned To · GH Fundamental State →Transitioned To · GH BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · GH CAPEX_INTENSITY_INCREASED →Transitioned To · GH CASH_GENERATION_INCREASED →Transitioned To · GH GROWTH_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.